| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 04/20/2011 | CN101263921B Preparation of olive health care beverage |
| 04/20/2011 | CN101254280B Coronary circulation promoting, intelligence benefiting Chinese medicine for curing vascular dementia |
| 04/20/2011 | CN101254279B Health care traditional Chinese medicine |
| 04/20/2011 | CN101199534B Anti-tumor function of raw panoxadiol derivative |
| 04/20/2011 | CN101023967B Compound extract of common phellinus fungus and chaga, its preparing method and preparation |
| 04/19/2011 | US7928255 Intermediates for the preparation of lipoxin A4 analogs |
| 04/19/2011 | US7928219 chemically modified nucleic acid molecule; cancer; carcinoma, neovascularization, diabetic retinopathy, neovascular glaucoma, myopic degeneration and other proliferative diseases, restenosis and polycystic kidney disease |
| 04/19/2011 | US7928218 Treatment of any disease that responds to modulation of gene expression, for example cancer, proliferative, inflammatory, metabolic, autoimmune, neurologic, ocular diseases; in vivo stability and bioavailability |
| 04/19/2011 | US7928143 Method for preventing and/or treating neurodegenerative diseases |
| 04/19/2011 | US7928130 Isoxazoline compounds having MIF antagonist activity |
| 04/19/2011 | US7928128 Use of(R)-(−) -2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]-chromane and its physiologically acceptable salts |
| 04/19/2011 | US7928125 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 04/19/2011 | US7928124 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 04/19/2011 | US7928119 Use of EP4 receptor ligands in the treatment of IL-6 involved diseases |
| 04/19/2011 | US7928099 Pyrimido [4,5-D] azepine derivatives as 5-HT2c agonists |
| 04/19/2011 | US7928071 Nucleotide and protein sequences of vertebrate delta genes and methods based thereon |
| 04/19/2011 | US7927824 Complex of a chaperone with β-amyloid and methods employing this complex |
| 04/19/2011 | US7927811 Binds to cerebrovascular endothelial cell; expression vectors; micelle, liposome or microcapsule used as carriers |
| 04/19/2011 | US7927624 Hydrophilic/lipophilic polymeric matrix dosage formulation |
| 04/19/2011 | US7927622 Methods of transnasal transport/immunization with highly adaptable carriers |
| 04/19/2011 | CA2640482C Novel pyridinylaminoalkylene- and pyridinyloxyalkylene-cyclopropanamines, process for the preparation thereof and pharmaceutical compositions containing them |
| 04/19/2011 | CA2601289C Once-a-day oxycodone formulations |
| 04/19/2011 | CA2596241C Methods and pharmaceutical compositions useful for treating neurological disorders |
| 04/19/2011 | CA2591257C Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analgetics |
| 04/19/2011 | CA2571133C Fused benzamide compound and vanilloid receptor 1 (vr1) activity inhibitor |
| 04/19/2011 | CA2560417C 1,2-diarylimidazole-4-carboxamide derivatives |
| 04/19/2011 | CA2486495C 9-alpha-substituted estratrienes as selectively active estrogens |
| 04/19/2011 | CA2476012C Substituted pyridinones as modulators of p38 map kinase |
| 04/19/2011 | CA2458452C Gnrh agonist combination drugs |
| 04/19/2011 | CA2450946C Use of branched-chain fatty acids and derivatives thereof for the treatment of pain |
| 04/19/2011 | CA2445048C Preparations containing afamin for treating oxidative stress-induced neurogenerative disease |
| 04/19/2011 | CA2441099C Proanthocyanidins for the treatment of amyloid and alpha-synuclein diseases |
| 04/19/2011 | CA2385659C Novel antiarrhythmic peptides |
| 04/19/2011 | CA2378778C Il-16 antagonists |
| 04/19/2011 | CA2373808C Bone marrow transplantation for treatment of central nervous system damage |
| 04/19/2011 | CA2370289C Neuronal exocytosis inhibiting peptides and cosmetic and pharmaceutical compositions containing said peptides |
| 04/14/2011 | WO2011044537A2 Methods for treating alzheimer's disease |
| 04/14/2011 | WO2011044535A2 8-ethyl-6-(aryl)pyrido[2,3-d]pyrimidin-7(8h)-ones for the treatment of cns disorders |
| 04/14/2011 | WO2011044516A2 Compositions and methods comprising pediococcus for reducing at least one symptom associated with autism spectrum disease in a person diagnosed with an autism spectrum disease |
| 04/14/2011 | WO2011044434A2 A composition and a method of treating cns disorders and hyperpigmentation |
| 04/14/2011 | WO2011044394A1 Purine derivatives useful as hsp90 inhibitors |
| 04/14/2011 | WO2011044375A2 Apogossypolone derivatives as anticancer agents |
| 04/14/2011 | WO2011044264A2 Pyrrolopyrazoles for treating cns disorders |
| 04/14/2011 | WO2011044230A2 N-acetylcysteine amide (nac amide) for the treatment of diseases and conditions |
| 04/14/2011 | WO2011044225A1 Modulators of g protein-coupled receptor 88 |
| 04/14/2011 | WO2011044212A1 Modulators of g protein-coupled receptor 88 |
| 04/14/2011 | WO2011044195A1 Modulators of g protein-coupled receptor 88 |
| 04/14/2011 | WO2011044082A2 Compositions and methods for inhibiting madcam |
| 04/14/2011 | WO2011043844A1 Compositions of stem cells and stem cell factors and methods for their use and manufacture |
| 04/14/2011 | WO2011043788A2 Daptomycin for multiple sclerosis |
| 04/14/2011 | WO2011043735A1 A composition for modulating immune responses |
| 04/14/2011 | WO2011043453A1 Activator for peroxisome proliferator activated receptor |
| 04/14/2011 | WO2011043387A1 Pyrazoloxazole compound |
| 04/14/2011 | WO2011043381A1 Pyrazolothiazole compound |
| 04/14/2011 | WO2011043371A1 Oxazole compound |
| 04/14/2011 | WO2011042872A1 Use of a dna replication inhibitor for treating neurodegenerative diseases caused by polyglutamine expansion |
| 04/14/2011 | WO2011042812A1 Use of rasagiline for the treatment of progressive supranuclear palsy |
| 04/14/2011 | WO2011042701A1 Compositions for the prevention or treatment of migraine |
| 04/14/2011 | WO2011042497A1 Pyrrolo [3,2 -e] [1,2,4] triazolo [1,5-a] pyrimidines derivatives as inhibitors of microglia activation |
| 04/14/2011 | WO2011042496A1 Pyrrolo [3, 2 -e] [1,2,4] triazolo [1,5 -a] pyrimidines derivatives as inhibitors of microglia activation |
| 04/14/2011 | WO2011042477A1 Substituted pyrroles and imidazoles as estrogen receptor ligands |
| 04/14/2011 | WO2011042475A1 Substituted pyrazoles as estrogen receptor ligands |
| 04/14/2011 | WO2011042473A2 Novel estrogen receptor ligands |
| 04/14/2011 | WO2011042343A1 Indane-amine derivatives, their preparation and use as medicaments |
| 04/14/2011 | WO2011041897A1 Compositions and methods for the transport of therapeutic agents |
| 04/14/2011 | WO2011017634A8 Prodrugs of fused heterocyclic inhibitors of d-amino acid oxidase |
| 04/14/2011 | WO2011015936A3 An improved process for the preparation of pure paliperidone |
| 04/14/2011 | WO2010138379A3 Methods of treating chronic neurogenic inflammation using a modified clostridial toxin |
| 04/14/2011 | WO2010096470A4 Method for inhibiting neurodegeneration |
| 04/14/2011 | US20110087153 Transdermal Methods And Systems For The Delivery Of Rizatriptan |
| 04/14/2011 | US20110086925 Method and System to Detect, Diagnose, and Monitor the Progression of Alzheimer's Disease |
| 04/14/2011 | US20110086921 Novel Polymorphic Forms of (4--2-Methylphenyl)Carbonyl]Amino}-3-Methylphenyl)Acetic Acid |
| 04/14/2011 | US20110086914 Methods for Treating Traumatic Brain Injury |
| 04/14/2011 | US20110086908 Use of phosphatase inhibitors for the treatment of neurodegenerative diseases |
| 04/14/2011 | US20110086903 Emergence of a r-type ca2+ channel (cav 2.3) contributes to cerebral artery constriction following subarachnoid hemorrhage |
| 04/14/2011 | US20110086899 Pharmaceutical compositions for oral administration |
| 04/14/2011 | US20110086898 Pyrazolooxazole compound |
| 04/14/2011 | US20110086894 Biomarkers for the diagnosis of als |
| 04/14/2011 | US20110086893 Oxa- and thiadiazoles and their use as metalloproteinase inhibitors |
| 04/14/2011 | US20110086889 Tetrazole compounds as orexin receptor antagonists |
| 04/14/2011 | US20110086883 Novel benzimidazole derivatives useful as selective androgen receptor modulators (sarms) |
| 04/14/2011 | US20110086882 Pyrazolothiazole compound |
| 04/14/2011 | US20110086880 Novel alkyl substituted piperidine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 04/14/2011 | US20110086879 Carboxamide compounds and their use as calpain inhibitors |
| 04/14/2011 | US20110086878 Treatments for Neuropathy |
| 04/14/2011 | US20110086875 Powdered Medicament for Nasal Delivery of Ascorbic Acid for Reducing Apomorphine Induced Toxicity to Ciliated Tissue |
| 04/14/2011 | US20110086874 Methods of Converting a Patient's Treatment Regimen from Intravenous Administration of an Opioid to Oral Co-Administration of Morphine and Oxycodone Using a Dosing Algorithm to Provide Analgesia |
| 04/14/2011 | US20110086873 Methods of Converting a Patient's Treatment Regimen from Intravenous Administration of an Opioid to Oral Co-Administration of Morphine and Oxycodone Using a Dosing Algorithm to Provide Analgesia |
| 04/14/2011 | US20110086867 6-(c2-6alkylseleno)purines and methods for treating neural measles viral infection therewith |
| 04/14/2011 | US20110086864 N-hydroxyamide derivatives and use thereof |
| 04/14/2011 | US20110086863 Benzenesulfonanilide compounds suitable for treating disorders that respond to modulation of the serotonin 5-ht6 receptor |
| 04/14/2011 | US20110086862 Polymorphs of pardoprunox |
| 04/14/2011 | US20110086860 Compound |
| 04/14/2011 | US20110086859 Alkyl substituted indoloquinoxalines |
| 04/14/2011 | US20110086857 N-((1r,2s,5r)-5-(tert-butylamino)-2-((s)-3-(7-tert-butylpyrazolo[1,5-a][1,3,5]triazin-4-ylamino)-2-oxopyrrolidin-1-yl)cyclohexyl)acetamide, a dual modulator of chemokine receptor activity, crystalline forms and processes |
| 04/14/2011 | US20110086856 Compositions useful as inhibitors of protein kinases |
| 04/14/2011 | US20110086855 Novel compounds as cannabinoid receptor ligands and uses thereof |
| 04/14/2011 | US20110086853 Therapeutic Compounds |
| 04/14/2011 | US20110086849 novel benzoxazine benzimidazole derivative, a pharmaceutical composition comprising the same, and ause thereof |
| 04/14/2011 | US20110086847 Thiadiazole modulators of beta adrenergic receptor |